CD56, CD57, HBME1, CK19, GALECTIN-3 AND P63 IMMUNOHISTOCHEMICAL STAINS IN DIFFERENTIATING DIAGNOSIS OF THYROID BENIGN/MALIGN LESIONS AND NIFTP

Creative Commons License

TAŞTEKİN E., Keskin E. U., CAN N., Canberk S., Mut A. N. U., Erdogan E. G., ...Daha Fazla

POLISH JOURNAL OF PATHOLOGY, cilt.70, sa.4, ss.286-294, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 70 Sayı: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5114/pjp.2019.93131
  • Dergi Adı: POLISH JOURNAL OF PATHOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.286-294
  • Anahtar Kelimeler: thyroid lesions, differential diagnosis, CK19, Galectin-3, CD56, CD57, p63, HBME1, FOLLICULAR VARIANT, LEU-7 ANTIGEN, EXPRESSION, BENIGN, CARCINOMA, TUMORS, CYTOKERATIN-19, CD56/N-CAM, NEOPLASMS, MARKERS
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Detection of thyroid carcinoma has been steadily increased in the past few decades. After the recognition of NIFTP, also gain importance to differentiate benign tumors (follicular adenoma) from follicular patterned variants of papillary thyroid carcinoma (invasive and infiltrative follicular variant papillary thyroid carcinoma), and low-risk lesions of thyroid (NIFTP).